Blockbuster merger between two drug giants imminent
US-based Pfizer in talks to buy Dublin based Allergan for as much as $380 a share
A mega merger between Pfizer and Allergan could come as early as Monday - valuing the Irish Botox-maker as high as $150bn.
US based Pfizer is understood to be in advanced talks to buy Dublin-domiciled Allergan for as much as $380 a share.
The proposed deal, still under negotiation, would probably see Pfizer redomicile in Ireland, where Allergan is registered and corporation taxes are much lower.
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Tom Maguire: Tax changes we make now could help business for years
The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures
The Daily Briefing
What’s coming up today and what you might have missed
The Daily Briefing
What’s coming up today and what you might have missed.
